Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.63%1.07B | 23.32%954.53M | 66.95%951.95M | 58.10%3.25B | 87.08%986.68M | 80.62%912.64M | 54.63%774.01M | 8.83%570.21M | 26.24%2.06B | 3.56%527.42M |
| Cost of revenue | 17.55%878.63M | 17.94%770.75M | 51.94%774.79M | 45.93%2.73B | 68.62%808.68M | 62.60%747.43M | 43.89%653.5M | 7.27%509.94M | 24.79%1.87B | 3.07%479.58M |
| Gross profit | 17.99%194.93M | 52.50%183.78M | 193.90%177.16M | 178.70%525.13M | 272.12%178M | 262.19%165.21M | 159.74%120.51M | 24.08%60.28M | 42.68%188.42M | 8.84%47.83M |
| Operating expense | -1.12%78.45M | 142.58%113.85M | 146.19%90.05M | 136.52%307M | 314.52%83.76M | 187.29%79.33M | 86.48%46.93M | 53.67%36.58M | 29.06%129.8M | -189.74%-39.05M |
| Selling and administrative expenses | 25.47%117.6M | 65.34%114.14M | 150.02%104.83M | 136.52%307M | 206.89%123.38M | 204.64%93.72M | 145.62%69.04M | 58.10%41.93M | 29.06%129.8M | 36.25%40.2M |
| -Selling and marketing expense | ---- | ---- | ---- | 54.23%31.33M | ---- | ---- | ---- | ---- | 40.22%20.32M | ---- |
| -General and administrative expense | 25.47%117.6M | 65.34%114.14M | 150.02%104.83M | 151.78%275.67M | 206.89%123.38M | 204.64%93.72M | 145.62%69.04M | 58.10%41.93M | 27.18%109.49M | 167.69%40.2M |
| Total other operating income | 172.08%39.15M | -98.69%289K | 176.20%14.78M | 8.09%88.05M | -50.01%39.62M | 356.83%14.39M | 652.25%22.1M | 96.91%5.35M | --81.46M | --79.25M |
| Operating profit | 35.65%116.49M | -4.96%69.93M | 267.54%87.11M | 272.11%218.14M | 8.48%94.24M | 377.12%85.88M | 246.60%73.58M | -4.34%23.7M | 86.21%58.62M | 19,780.78%86.88M |
| Net non-operating interest income (expenses) | -24.08%-23.98M | -27.60%-22.15M | -78.13%-22.74M | -86.73%-68.14M | -82.69%-19.12M | -115.15%-19.32M | -85.05%-17.36M | -66.66%-12.77M | -38.82%-36.49M | -70.61%-10.47M |
| Non-operating interest income | -16.86%2.87M | 54.55%1.53M | 39.31%1.77M | 157.59%10.37M | 225.85%4.6M | 172.06%3.45M | 132.94%990K | 38.11%1.27M | 21.64%4.03M | -19.73%1.41M |
| Non-operating interest expense | 17.88%26.84M | 29.05%23.68M | 74.62%24.52M | 93.77%78.51M | 99.71%23.72M | 122.19%22.77M | 87.12%18.35M | 63.60%14.04M | 36.90%40.52M | 50.48%11.88M |
| Net investment income | 12,235.17%17.89M | 12,235.17%17.89M | 145K | 122.94%145K | 145K | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -198.92%-4.49M | -42.58%8.99M | -193.59%-5.44M | 547.62%51.45M | 137,900.00%6.89M | 660.30%4.54M | 1,010.43%15.66M | -2.10%5.82M | 262.41%7.94M | 99.99%-5K |
| Income from associates and other participating interests | -32.09%1.47M | 16.84%3.21M | 238.14%8.2M | -79.34%13.71M | -73.68%6.67M | -78.53%2.17M | -85.58%2.74M | -79.64%2.43M | 112.66%66.37M | 119.87%25.35M |
| Special income (charges) | -131.81%-2.59M | 0 | -16.95%-1.96M | 29.50%-1.77M | 21.09%-1.71M | -88.33%8.14M | -86.71%6.83M | |||
| Less:Other special charges | ---- | ---- | ---- | 0.00%-7.94M | ---- | ---- | ---- | ---- | 90.13%-7.94M | 87.91%-6.83M |
| Less:Write off | ---- | ---- | ---- | 1,434.02%2.59M | ---- | 16.95%1.96M | -51.12%1.77M | -21.09%1.71M | -101.83%-194K | ---- |
| Other non-operating income (expenses) | -46.34%45.39M | 849.23%84.6M | ||||||||
| Income before tax | -0.90%72.6M | -19.79%59.97M | 250.06%67.12M | 45.70%275.85M | -1.99%106.57M | 306.41%73.26M | 151.20%74.76M | -41.54%19.17M | 62.42%189.32M | 392.38%108.73M |
| Income tax | 5.35%19.85M | 37.67%17.41M | 285.15%20.67M | 126.75%60.35M | 155.53%23.05M | 197.72%18.84M | 159.99%12.65M | -16.20%5.37M | 70.71%26.62M | 173.42%9.02M |
| Net income | -3.07%52.75M | -31.48%42.56M | 236.42%46.45M | 32.45%215.49M | -16.24%83.52M | 365.21%54.42M | 149.48%62.12M | -47.69%13.81M | 61.14%162.7M | 430.84%99.71M |
| Net income continuous operations | -3.07%52.75M | -31.48%42.56M | 236.42%46.45M | 32.45%215.49M | -16.24%83.52M | 365.21%54.42M | 149.48%62.12M | -47.69%13.81M | 61.14%162.7M | 430.84%99.71M |
| Noncontrolling interests | -1.52%25.41M | 5.07%20.13M | 585.04%27.16M | 469.51%97.08M | 534.68%47.98M | 23,571.56%25.8M | 532.66%19.16M | -37.55%3.97M | 311.24%17.05M | 142.77%7.56M |
| Net income attributable to the company | -4.47%27.34M | -47.78%22.43M | 95.99%19.29M | -18.70%118.41M | -61.44%35.54M | 146.93%28.61M | 96.42%42.96M | -50.90%9.84M | 50.43%145.66M | 488.09%92.15M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 39.11%1.32M | 25.80%1.18M | 20.88%932K | 3.6M | 945K | 946K | 934K | 771K | 0 | 0 |
| Net income attributable to common stockholders | -5.96%26.02M | -49.42%21.26M | 102.37%18.36M | -21.17%114.82M | -62.46%34.59M | 138.76%27.67M | 92.15%42.02M | -54.74%9.07M | 50.43%145.66M | 488.09%92.15M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.13%0.0074 | -49.58%0.006 | 1.96%0.0052 | -25.00%0.03 | -62.31%0.0098 | 140.00%0.0078 | 91.94%0.0119 | -9.73%0.0051 | 60.00%0.04 | 487.17%0.026 |
| Diluted earnings per share | -5.13%0.0074 | -49.58%0.006 | 1.96%0.0052 | -25.00%0.03 | -62.31%0.0098 | 140.00%0.0078 | 91.94%0.0119 | -9.73%0.0051 | 60.00%0.04 | 487.17%0.026 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.